SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Lab may part away with Lipitor rights: Report

19 Aug 2011 Evaluate

Ranbaxy Laboratories may part away with its rights to make a generic version of Pfizer Inc's Lipitor, the world's best-selling medicine, if it fails to win timely US approval for the cholesterol pill as stated in some media reports.

A legal settlement with Pfizer gave Ranbaxy six months' exclusivity to market generic Lipitor in the US. However, delays in Food and Drug Administration approval may prevent the Indian company from selling its copies as planned from November 30.

An FDA investigation into quality standards at two Ranbaxy manufacturing plants and a federal investigation into its testing practices have delayed approval of the drug copy. However, there are reports stating that the Federal prosecutors are negotiating a dispute settlement that may cost Ranbaxy more than $1 billion.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×